• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of June 19, 2013

  • Print
  • Share
  • E-mail
-

Product Detail

Product Description Source Plasma
Recall Number B-1375-13
Classification Class II
Code Info 08IIAE8374; 08IIAE7282; 08IIAE6595; 08IIAH2718; 08IIAH2425; 08IIAH1074; 08IIAH0557; 08IIAG9210; 08IIAG8336; 08IIAG7285; 08IIAG5669; 08IIAG5288; 08IIAG3787; 08IIAG3355; 08IIAG1886; 08IIAG1450; 08IIAF3267; 08IIAF2468; 08IIAE5604; 08IIAE5050; 08IIAE3681; 08IIAE2740; 08IIAE1500; 08IIAE0848; 08IIAD9640; 08IIAD8918; 08IIAD7411; 08IIAD6779; 08IIAD6080; 08IIAD5535; 08IIAD4770; 08IIAD3972; 08IIAD2489; 08IIAD1217; 08IIAD0504; 08IIAD0018; 08IIAC7994; 08IIAC7250; 08IIAC5888; 08IIAC5172; 08IIAC0381; 08IIAB9637; 08IIAB8792; 08IIAB7823; 08IIAB5804; 08IIAB5391; 08IIAB4303; 08IIAB3433; 08IIAB2935; 08IIAB2212; 07IIAA4595; 07IIAA1170; 07IIAA0797; 07IIAA0285; 06IIAC4233; 06IIAC3869
Product Distributed Qty 56 Units
Reason For Recall Blood products, collected from a donor with a history of Hepatitis A, were distributed.

Event Detail

Event Id 52245
Product Type Biologics
Status Terminated
Recalling Firm BioLife Plasma Services LP
City Coralville
State IA
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2009-04-07
Initial Firm Notification of Consignee or Public FAX
Distribution Pattern CA
-
-